iSpecimen Inc. (ISPC) pays $97,500 to settle WestPark Capital arbitration
Rhea-AI Filing Summary
iSpecimen Inc. entered into a Settlement Agreement and Mutual Release with WestPark Capital, Inc. on August 6, 2026 to resolve all disputes, including an arbitration in which WestPark had sought $269,999.91 plus interest, fees, and costs. Under the agreement, iSpecimen paid WestPark $97,500 in full satisfaction of all claims, and WestPark dismissed the arbitration with prejudice, with each party bearing its own fees and costs. The parties granted each other a mutual general release, agreed to terminate the prior engagement agreements in their entirety (including any tail fee and right of first refusal), and accepted mutual confidentiality obligations and New York governing law with binding JAMS arbitration for disputes. iSpecimen expects to record the $97,500 as a charge in the quarter ending September 30, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 1.01, 1.02, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 1.02
Termination of a Material Definitive Agreement
Business
A significant contract was terminated, which may affect business operations or revenue.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Settlement Payment: $97,500
Damages Sought in Arbitration: $269,999.91
Underwritten Offering Gross Proceeds: approximately $4.0 million
+1 more
4 metrics
Settlement Payment
$97,500
Amount paid by iSpecimen to WestPark in full satisfaction of all claims
Damages Sought in Arbitration
$269,999.91
Claims asserted by WestPark in the arbitration before settlement
Underwritten Offering Gross Proceeds
approximately $4.0 million
Gross proceeds from iSpecimen’s underwritten public offering that closed on July 25, 2025
Settlement Charge Period
quarter ending September 30, 2026
Period when iSpecimen expects to record the $97,500 settlement charge
Key Terms
Settlement Agreement and Mutual Release, mutual general release, tail fee, right of first refusal, +1 more
5 terms
Settlement Agreement and Mutual Release regulatory
"entered into a Settlement Agreement and Mutual Release with WestPark"
mutual general release regulatory
"provides for (i) a mutual general release of all claims between the parties"
tail fee financial
"including any tail fee, right of first refusal, or other surviving provisions"
right of first refusal financial
"including any tail fee, right of first refusal, or other surviving provisions"
A right of first refusal gives an existing shareholder or party the chance to buy an asset or shares before the owner can sell them to someone else. Think of it like being offered the first option to buy a house when the owner decides to sell; it matters to investors because it can limit who can acquire a stake, slow or block transactions, and affect the price and liquidity of an investment by restricting open-market sales or new buyers.
binding JAMS arbitration regulatory
"New York governing law with disputes subject to binding JAMS arbitration"
FAQ
What dispute did iSpecimen (ISPC) resolve with WestPark Capital?
iSpecimen resolved an arbitration with WestPark Capital relating to engagement agreements for investment banking services, including an underwritten public offering. WestPark had sought $269,999.91 in damages, plus interest, fees, and costs, which are now settled under a new agreement.
How much did iSpecimen (ISPC) agree to pay in the settlement with WestPark?
iSpecimen agreed to pay WestPark $97,500 as a settlement payment. This amount fully satisfies all claims covered by the arbitration and related disputes and will be recorded as a charge in the quarter ending September 30, 2026.
What happened to the arbitration between iSpecimen (ISPC) and WestPark Capital?
Following the settlement, WestPark filed a notice on August 10, 2026 dismissing the arbitration and all claims with prejudice. Each party will bear its own fees and costs, and both granted a mutual general release of claims through the settlement’s effective date.
Were iSpecimen’s engagement agreements with WestPark Capital terminated?
Yes. The settlement terminated the prior engagement agreements between iSpecimen and WestPark in their entirety. This includes ending any tail fee, right of first refusal, or other surviving provisions from those underwriter engagement arrangements.
What offering was covered by the terminated engagement agreements for iSpecimen (ISPC)?
The terminated engagement agreements governed WestPark’s role as underwriter for iSpecimen’s underwritten public offering that closed on July 25, 2025. That offering raised gross proceeds of approximately $4.0 million for the company.
How will the settlement payment affect iSpecimen’s (ISPC) financials?
iSpecimen expects to record the $97,500 settlement payment as a charge in its financial statements for the quarter ending September 30, 2026. No early termination penalties were incurred when the engagement agreements were ended.
AI-generated analysis. How Rhea-AI works. Not financial advice.
